Molecular basis of ethnic differences in drug disposition and response.

By Hong‐Guang Xie, R. Kim, A. J. Wood, C. Stein. Annual Review of Pharmacology and Toxicology, 2001

618 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Oncology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/98a8acd8f54def153e3e828ac68174094cc15717

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. Magnus Ingelman-Sundberg

In Oncology

1. C. Rodríguez‐Antona
2. A. Gomez
3. S. Sim
4. Magnus Ingelman-Sundberg

In Pharmacology

1. C. Rodríguez‐Antona
2. A. Gomez
3. S. Sim
4. Magnus Ingelman-Sundberg

Citations in the corpus

• Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. (2007, background): “The CYP3A7⁎2 SNP has an allele frequency of 8%, 28% and 62% in Caucasians, Asians and Africans, respectively, and encodes an enzyme with a moderately higher activity than CYP3A7.”
• Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (2002, neutral): “[24]].”
• Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine (2016, background): “Lansoprazole, omeprazole Gastroenterology PM Increased half-life leading to high cure rates in individuals with PM genotypes, which is reversed in EMs [83,84]”